A clinical trial of Acitab-M125 tablet in Hyperacidity.

A pilot study to evaluate efficacy of Acitab-M125 tablet in the patients with mild to moderate Hyperacidity (Amlapitta). - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076713

Enrollment

Registered

2024-11-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R12- Heartburn

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: -Participants aged 18-65 years irrespective of sex. -Person suffering with symptoms like heartburn, nausea, etc. related to Hyperacidity -Willingness to comply with study requirements and follow instructions. -Ability to provide informed consent.

Exclusion criteria

Exclusion criteria: -Individuals with known allergies to the content of the product. -Pregnant or breastfeeding women. -Individuals with associated comorbidities. -Recent participation in another clinical trial. -Current substance abuse or dependence. -Significant mental illness or medical condition.

Design outcomes

Primary

Measure	Time frame
To relieve Hyperacidity (AMLAPITTA) symptoms.Timepoint: 14 days study with follow up on 7th and 14th day.	—

Secondary

Measure	Time frame
To observe drug safety and efficacy.Timepoint: 14 days study with follow up on 7th and 14th day.	—

Countries

India

Contacts

Public ContactDr Yogesh Kutte

Dr D Y Patil College of Ayurved and Research Center Pimpri Pune

yogesh.kutte@dpu.edu.in9403984664

Outcome results